title: [Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report].
abstract: Insertion of a transjugular intrahepatic portosystemic shunt (TIPS) is an increasingly used treatment in the management of the complications of portal hypertension. However, one of the complications of this technique is refractory or recurrent hepatic encephalopathy, which poses a difficult clinical problem. We report the case of a patient who underwent TIPS insertion to control bleeding due to esophageal varices. The patient subsequently developed refractory hepatic encephalopathy, requiring reduction of the caliber of the shunt.
authors.affiliation: Unidad Hepática, Hospital General y Universitario de Alicante, Alicante, España.
authors.forename: Belén
authors.initials: B
authors.lastname: Martínez Moreno
authors.forename: Pablo
authors.initials: P
authors.lastname: Bellot
authors.forename: Francisco
authors.initials: F
authors.lastname: de España
authors.forename: José María
authors.initials: JM
authors.lastname: Palazón
authors.forename: José
authors.initials: J
authors.lastname: Such
authors.forename: Miguel
authors.initials: M
authors.lastname: Pérez-Mateo
mesh_terms: D001201:Ascites / Q000188:drug therapy / Q000209:etiology; D057510:Endovascular Procedures / Q000295:instrumentation / Q000379:methods*; D004867:Equipment Design; D004932:Esophageal and Gastric Varices / Q000209:etiology / Q000601:surgery; D005665:Furosemide / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000601:surgery; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000601:surgery*; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000601:surgery; D007601:Jugular Veins; D008102:Liver Circulation; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications; D008297:Male; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D011183:Postoperative Complications / Q000209:etiology / Q000601:surgery*; D011433:Propranolol / Q000627:therapeutic use; D012086:Reoperation; D013148:Spironolactone / Q000627:therapeutic use; D015607:Stents
chemical_list: D013148:Spironolactone; D005665:Furosemide; D011138:Polytetrafluoroethylene; D011433:Propranolol